Yonsei University: Colorectal Neoplasms trials

The registry lists 22 Colorectal Neoplasms studies with Yonsei University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 2Phase 4 1No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Intervention to Reduce Sedentary Behavior and Promote Physical Activity in Colorectal Cancer ChemotherapyNot yet recruitingNCT07845877Not applicable
• Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis TechniquesRecruitingNCT07035587
• An Open-label, Single-arm, Multicenter Phase II Study to Evaluate the Efficacy of Amivantamab in Combination With FOLFIRI as a Second-line Treatment in Patients With RAS/BRAF Wild-type Advanced Colorectal Cancer Progressing on Prior Anti-EGFR Based Treatment.Not yet recruitingNCT06855849Phase 2
• Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous PolyposisRecruitingNCT06545526Phase 3
• Plasma Biomarker for Aflibercept in Advanced Colorectal CancerRecruitingNCT04810585Phase 4
• Effect of Exercise on Bowel Function in Colorectal Cancer SurvivorsCompletedNCT05420870Not applicable
• Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal MetastasesStatus unknownNCT05103020Phase 2
• CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapyStatus unknownNCT04704960
• Niclosamide for Familial Adenomatous PolyposisStatus unknownNCT04296851Phase 2
• Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel ExpressionStatus unknownNCT03289988
• The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer ResectionStatus unknownNCT03273231Not applicable
• Pemetrexed and Erlotinib for Metastatic Colorectal CancerCompletedNCT02723578Phase 2
• Liver MRI for Colorectal Cancer Liver Metastasis: Comparative Effectiveness Research for the Choice of Contrast AgentsStatus unknownNCT02652663
• Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal ObstructionStatus unknownNCT02640781Not applicable
• Effect of Adjunctive Metformin on Recurrence of Non-DM Colorectal Cancer Stage II High-risk/ III Colorectal CancerStatus unknownNCT02614339Phase 3
• The Benefits of Deep Neuromuscular Block and Sugammadex in Laparoscopic Colorectal SurgeryCompletedNCT02266056Not applicable
• Factors Influencing Quality of Bowel Cleansing for Colonoscopy in Patients With Colorectal Cancer Surgery; Prospective Observational StudyTerminatedNCT02139475
• A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable MetastasisTerminatedNCT01978249Not applicable
• Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver MetsCompletedNCT01632722Phase 2
• Influence of Tumor Associated Immunity on the Number of Lymph Node Retrieved After Colorectal Cancer Surgery (Preliminary Study)CompletedNCT01629524
• Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis PatientsCompletedNCT01318239Not applicable
• Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanStatus unknownNCT00496704Phase 1/2